ACC 2020: SPYRAL HTN-OFF MED Results Support Medtronic’s Renal Denervation System

Three-month results of the SPYRAL HTN-OFF MED pivotal trial show renal denervation with Medtronic’s Symplicity Spyral system significantly reduced blood pressure in hypertensive patients not taking anti-hypertensive medications.

Cropped image of male doctor checking blood pressure of patient at table
• Source: shutterstock.com

[Editor's note: Complete historical information on important medical device trial announcements is available from Informa’s MedDeviceTracker.]

The complete three-month results of SPYRAL HTN-OFF MED show renal denervation with Medtronic PLC’s Symplicity Spyral system creates significant blood-pressure reductions in patients with uncontrolled hypertension who are...

More from Clinical Trials

More from R&D